Estadístiques de Long-term efficacy of rituximab in chronic ataxic neuropathy associated with anti-ganglioside antibodies
Visites totals
| views | |
|---|---|
| Long-term efficacy of rituximab in chronic ataxic neuropathy associated with anti-ganglioside antibodies | 81 |
Visites totals per mes
| views | |
|---|---|
| August 2024 | 15 |
| September 2024 | 4 |
| October 2024 | 0 |
| November 2024 | 4 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| Bertran_neu_long.pdf(legacy) | 107 |
| Bertran_neu_long.pdf | 31 |
Vistes principals per país
| views | |
|---|---|
| United States | 61 |
| Belgium | 5 |
| Spain | 4 |
| France | 2 |
| India | 2 |
| Sweden | 2 |
| Australia | 1 |
| United Kingdom | 1 |
| Mexico | 1 |
| Malaysia | 1 |
| Romania | 1 |
Visites principals per ciutat
| views | |
|---|---|
| San Ramon | 15 |
| Menlo Park | 7 |
| Madrid | 4 |
| Tustin | 4 |
| Boardman | 3 |
| Falls Church | 3 |
| Mountain View | 3 |
| Ann Arbor | 2 |
| Ashburn | 2 |
| Airoli | 1 |
| Andover | 1 |
| Bucharest | 1 |
| Dearborn | 1 |
| Hermosillo | 1 |
| Mumbai | 1 |
| Pinjarra | 1 |
| Salt Lake City | 1 |
| San Diego | 1 |
| Shah Alam | 1 |